データなし
コード銘柄名
現在値変化額変化率出来高売買代金始値前日終値高値安値時価総額浮動株時価株式総数浮動株5日変化率10日変化率20日変化率60日変化率120日変化率250日変化率年初来配当利回売買回転率直近PER前年PER振幅業種
お気に入り
Failure of AstraZeneca's AZD4041 a Blow for Non-opioid OUD Treatments
安进(AMGN.US)发布减肥疗法MariTide中期数据 减重效果不输诺礼
阿斯利康(AZN.US)联合疗法Truqap组合3期试验结果积极
阿斯利康Capivasertib前列腺癌III期成功 来凯医药-B(2105.HK)AKT抑制剂前景看好
AstraZeneca Reports Positive Phase 3 Results for Truqap in Prostate Cancer
TRUQAP (Capivasertib) Combination in PTEN-deficient Metastatic Hormone-sensitive Prostate Cancer Demonstrated Statistically Significant and Clinically Meaningful Improvement in Radiographic Progression-free Survival in CAPItello-281 Phase III Trial